HER2-POSITIVE ADVANCED BREAST CANCER
Clinical trials for HER2-POSITIVE ADVANCED BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE ADVANCED BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2-POSITIVE ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HER2+ breast cancer: Real-World study tests daily pill pyrotinib
Disease control Not yet recruitingThis study will follow 500 people with HER2-positive advanced breast cancer who are starting treatment with pyrotinib, a daily oral targeted therapy. Researchers want to see how well the drug controls the cancer and what side effects occur in everyday medical practice, not just i…
Matched conditions: HER2-POSITIVE ADVANCED BREAST CANCER
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
AI tool aims to predict breast cancer drug success, sparing patients unnecessary side effects
Knowledge-focused Not yet recruitingThis study is developing an AI tool that analyzes tumor images, proteins, and patient data to predict whether a person with advanced HER2-positive or low-expression breast cancer will benefit from the targeted drug T-DXd. The goal is to avoid giving ineffective treatment, which c…
Matched conditions: HER2-POSITIVE ADVANCED BREAST CANCER
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC